EPHB4 belongs to the receptor tyrosine kinases (RTK) family, with widespread roles in physiological and pathological processes, and frequently upregulated in cancer cells through activation of the PI3K signaling pathway and related to poor prognosis [23]. This evidence concerns the gene EPHB4 and cancer.